Medical News

RSS

Pivotal Therapeutics reports net loss of $1.2 million for first quarter 2015

Pivotal Therapeutics Inc., a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced its operational highlights and financial results for the three months ended March 31, 2015.

2 Jun 2015

LaunchPad receives exclusive worldwide license for bone adhesive technology from Stryker

LaunchPad Medical, LLC announced today that it has entered into a definitive agreement to license Stryker Corporation's bone adhesive technology, which is based on a unique synthetic biomaterial. Under the terms of the agreement, LaunchPad has received an exclusive worldwide license from Stryker for this technology which is covered by four issued and three pending U.S. patents and includes data from multiple pre-clinical animal studies.

From Stryker 2 Jun 2015

SIRFLOX study promises better and earlier treatment option for liver cancer patients

The benefits of adding liver-directed SIR-Spheres Y-90 resin microspheres to a current systemic chemotherapy for the first-line treatment of unresectable metastatic colorectal cancer (mCRC) reported in the SIRFLOX study, were presented at the American Society of Clinical Oncology Annual Meeting in Chicago.

2 Jun 2015

miR-181b potential biomarker of replication, progression in chronic HBV

A Chinese team reports a correlation between serum levels of microRNA-181b and hepatitis B virus replication and disease progression in patients with chronic HBV infection.

1 Jun 2015

TDF alone may be sufficient maintenance in chronic HBV patients

Tenofovir disoproxil fumarate monotherapy may be sufficient to maintain complete virological suppression in patients with chronic hepatitis B virus infection previously treated with TDF plus entecavir, suggests a review of patients.

1 Jun 2015

Meta-analysis sheds light on effectiveness of chronic HBV treatments

A meta-analysis of treatments for chronic hepatitis B virus infection suggests that tenofovir disoproxil fumarate is the most effective option for patients positive and negative for hepatitis B e antigen, but the latter group may also benefit from entecavir treatment.

1 Jun 2015

ERC Advanced Grants awarded to seven ETH researchers

Seven ETH Zurich professors have applied successfully for an ERC Advanced Grant, which is worth about CHF 2.5 million. Two of the seven received the coveted award for the second time.

1 Jun 2015

Fertilization with high nitrogen:potassium ratio fertilizers reduces environmental effect of landscape palms

Palms are an important part of the environment in subtropical and warm temperate climates. Palms' aesthetics and small "footprints" make them desirable in a variety of landscapes throughout the southeastern United States.

1 Jun 2015

Long sleep duration recommended for adults to sustain health and safety

In a new recommendation published in the June issue of SLEEP, the American Academy of Sleep Medicine (AASM) and Sleep Research Society (SRS) recommend that adults obtain seven or more hours of sleep per night to avoid the health risks of chronic inadequate sleep.

1 Jun 2015

Academics from University of Zurich selected to receive EU's most prestigious research grant

Two male academics and one female academic from the University of Zurich have been selected to receive the EU's most prestigious research grant. Each will receive between 2.5 and 2.9 million Euro to support innovative research projects over the next five years.

1 Jun 2015

Poster related to Cantex's lead compound CX-01 presented at ASCO 2015

Cantex Pharmaceuticals, a clinical stage biopharmaceutical company developing medications that block critical mechanisms by which cancer spreads and resists treatment, today announced Tibor Kovacsovics, M.D., Medical Director for the Inpatient Service of the Division of Hematology and Hematologic Malignancies and Director of Hematologic Malignancy Clinical Research at Huntsman Cancer Institute presented a poster related to Cantex's lead compound, CX-01, at the 51st Annual Meeting of the American Society of Clinical Oncology (ASCO).

1 Jun 2015

Vaccines - a needle-free future? An interview with Thomas Johnston and Dr. Kees Leenhouts, Mucosis

Scientists recognize that 90% of pathogens actually enter the body through the mucosa and secondly, we have evolved a mucosal defense system that can be used to defend against disease...

1 Jun 2015

Modified poliovirus therapy for glioblastoma works best at a low dosage

A modified poliovirus therapy that is showing promising results for patients with glioblastoma brain tumors works best at a low dosage, according to the research team at Duke's Preston Robert Tisch Brain Tumor Center where the investigational therapy is being pioneered.

1 Jun 2015

HTMS expands care management consulting business to meet growing demand from healthcare systems

HTMS, an Emdeon company, today announced the expansion of its care management consulting business to meet the growing demand from hospitals and healthcare systems for consulting services around integrated care management programs.

1 Jun 2015

Contaminant particles emitted by vehicles have negative repercussions in children with respiratory illnesses

Particles of less than 2.5 microns emitted by vehicles have negative repercussions for bronchiolitis, pneumonia, asthma and bronchitis in children.

1 Jun 2015

Even during quiet moments, our brains are preparing us to be socially connected to other people

A new study by UCLA neuroscientists sheds light on why Facebook is such a popular diversion for people who feel like taking a break.

1 Jun 2015

Syndicate of investment dealers exercise over-allotment option to purchase shares of Merus Labs International

Merus Labs International Inc. is pleased to announce today that the syndicate of investment dealers (the "Underwriters") has exercised the over-allotment option to purchase 1,000,550 common shares of the Company ("Shares") at a price of C$3.05 per Share granted to the Underwriters in connection with the Company's previously announced public offering which closed on April 30, 2015.

1 Jun 2015

Smoking cannabis may reduce chances of infection by intestinal worms

Washington State University researchers have found that the more hunter-gatherers smoke cannabis, the less they are infected by intestinal worms. The link suggests that they may unconsciously be, in effect, smoking medical marijuana.

1 Jun 2015

National Psoriasis Foundation’s online research community receives second-year of funding from PCORI

The National Psoriasis Foundation received a second-year of funding from the Patient-Centered Outcomes Research Institute (PCORI) for its patient-driven, online research community.

1 Jun 2015

North American Spine Society issues formal coverage recommendation for MIS SI joint fusion

SI-BONE, Inc., a medical device company that pioneered the use of the iFuse Implant System®, a minimally invasive surgical (MIS) device indicated for fusion for certain disorders of the sacroiliac (SI) joint, announced that the North American Spine Society (NASS) has issued their formal coverage recommendation for MIS SI joint fusion titled "Percutaneous Sacroiliac Joint Fusion, Defining Appropriate Coverage Positions."

1 Jun 2015

Medical News

Pivotal Therapeutics reports net loss of $1.2 million for first quarter 2015

LaunchPad receives exclusive worldwide license for bone adhesive technology from Stryker

SIRFLOX study promises better and earlier treatment option for liver cancer patients

miR-181b potential biomarker of replication, progression in chronic HBV

TDF alone may be sufficient maintenance in chronic HBV patients

Meta-analysis sheds light on effectiveness of chronic HBV treatments

ERC Advanced Grants awarded to seven ETH researchers

Fertilization with high nitrogen:potassium ratio fertilizers reduces environmental effect of landscape palms

Long sleep duration recommended for adults to sustain health and safety

Academics from University of Zurich selected to receive EU's most prestigious research grant

Poster related to Cantex's lead compound CX-01 presented at ASCO 2015

Vaccines - a needle-free future? An interview with Thomas Johnston and Dr. Kees Leenhouts, Mucosis

Modified poliovirus therapy for glioblastoma works best at a low dosage

HTMS expands care management consulting business to meet growing demand from healthcare systems

Contaminant particles emitted by vehicles have negative repercussions in children with respiratory illnesses

Even during quiet moments, our brains are preparing us to be socially connected to other people

Syndicate of investment dealers exercise over-allotment option to purchase shares of Merus Labs International

Smoking cannabis may reduce chances of infection by intestinal worms

National Psoriasis Foundation’s online research community receives second-year of funding from PCORI

North American Spine Society issues formal coverage recommendation for MIS SI joint fusion

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News